Oculis
stage recap trial objectives met results validated loading and maintenance regimen to optimize efficacy potential in with robust statistical significance met all functional and clinical benefit in a robust statistically superior manner in month trial no unexpected safety findings observed next step commence stage of program to support filing of for treatment | Oculis
Company
Deck Type
Deck date
May 2023
Slide
26 of 30
Similar slides by Oculis
See diffirences between slides (animation)
Investor Presentation
July 2023
positive and solid stage next step continue diamond program with full weeks trials to support filing of for treatment | Oculis
Investor Conference
June 2023
stage results stage trial next step commence stage of phase program to support filing of for treatment | Oculis
Related slides by other companies
BioAtla
Investor Presentation
May 2023
is a clinical stage company focused on transforming cancer therapy | BioAtla
Kymera
Investor Presentation
August 2023
part summary | Kymera
Erasca
Investor Presentation
August 2023
proposed pivotal phase trial designs creative strategy includes high randomized melanoma trial and tissue agnostic indication | Erasca
Minerva
IPO
October 2021
clinical trials overview | Minerva
Other recent decks by Oculis
See all presentations (6 decks)
Results
August 2023
Investor Presentation
July 2023
Investor Conference
June 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io